Nissen, Emily
Reiner, Alexander
Liu, Simin
Wallace, Robert B.
Molinaro, Annette M.
Salas, Lucas A.
Christensen, Brock C.
Wiencke, John K.
Koestler, Devin C.
Kelsey, Karl T.
Funding for this research was provided by:
National Cancer Institute Cancer Center Support Grant P30 (CA168524)
Kansas IDeA Network of Biomedical Research Excellence Bioinformatics, supported by the National Institute of General Medical Science award P20 (GM103418)
Kansas Institute for Precision Medicine COBRE, supported by the National Institute of General Medical Science award P20 (GM130423)
Grant (X01HL139376)
CDMRP/Department of Defense (W81XWH-20-1-0778)
National Institute of General Medical Sciences (P20 GM104416)
National Cancer Institute (CA253976)
Article History
Received: 2 September 2022
Accepted: 19 April 2023
First Online: 28 April 2023
Declarations
:
: The WHI project was reviewed and approved by the Fred Hutchinson Cancer Research Center (Fred Hutch) IRB in accordance with the U.S. Department of Health and Human Services regulations at 45 CFR 46 (approval number: IR# 3467-EXT). Participants provided written informed consent to participate. Additional consent to review medical records was obtained through signed written consent. Fred Hutch has an approved FWA on file with the Office for Human Research Protections (OHRP) under assurance number 0001920.
: Not applicable.
: Drs. Kelsey and Wiencke are founders of Cellintec, which had no role in this research.